Institute of Cardiovascular Sciences, University of Birmingham, UK; Department of Cardiology, National Hospital Organization Kyoto Medical Center, Japan.
Institute of Cardiovascular Sciences, University of Birmingham, UK.
EBioMedicine. 2017 Apr;18:199-203. doi: 10.1016/j.ebiom.2017.03.022. Epub 2017 Mar 16.
Ethnic differences in clinical characteristics, stroke risk profiles and outcomes among atrial fibrillation (AF) patients may exist. We therefore compared AF patients with previous stroke from Japan and the United Kingdom (UK).
We compared clinical characteristics, stroke risk and outcomes among AF patients from the Fushimi AF registry who had experienced a previous stroke (Japan; n=688; 19.7%) and the Darlington AF registry (UK; n=428; 19.0%).
AF patients with previous stroke in Fushimi were significantly younger (76.8 and 79.6years of age in Fushimi and Darlington; p<0.01) with a lower proportion of females (37.4% vs. 45.1%; p=0.01) than those from Darlington. Although the CHADS-VASc score was lower in AF patients in Fushimi than those in Darlington (5.18 vs. 5.57; p<0.01), oral anticoagulation (OAC) was prescribed significantly more frequently in Fushimi (68.3%) than Darlington (61.7%) (p=0.02). Multivariate logistic regression analysis showed that Japanese ethnicity was associated with a significantly decreased risk of recurrent stroke (OR 0.59. 95% CI 0.36-0.97; p=0.04) but a significantly increased risk of all-cause mortality (OR 1.76, 95% CI 1.18-2.66; p<0.01) in AF patients with previous stroke.
AF patients with previous stroke in the UK were at higher risk of recurrent stroke compared to Japanese patients, but OAC was utilised less frequently. There was a lower risk of recurrent stroke in the secondary prevention cohort from the Fushimi registry, but an increased risk of all-cause mortality.
在房颤(AF)患者中,临床特征、卒中风险谱和结局可能存在种族差异。因此,我们比较了来自日本和英国(UK)的既往有卒中史的 AF 患者。
我们比较了来自日本藤森 AF 注册研究(Fushimi AF registry)和英国达灵顿 AF 注册研究(Darlington AF registry)既往有卒中史的 AF 患者(日本,n=688;19.7%;英国,n=428;19.0%)的临床特征、卒中风险和结局。
Fushimi 既往有卒中史的 AF 患者明显更年轻(76.8 和 79.6 岁,Fushimi 和 Darlington;p<0.01),女性比例更低(37.4% vs. 45.1%;p=0.01)。尽管 Fushimi 患者的 CHADS-VASc 评分低于 Darlington(5.18 vs. 5.57;p<0.01),但 Fushimi 患者服用口服抗凝剂(OAC)的比例明显高于 Darlington(68.3% vs. 61.7%;p=0.02)。多变量 logistic 回归分析显示,与英国患者相比,日本患者的种族与复发性卒中风险显著降低(OR 0.59,95%CI 0.36-0.97;p=0.04),但既往有卒中史的 AF 患者的全因死亡率风险显著增加(OR 1.76,95%CI 1.18-2.66;p<0.01)。
与日本患者相比,英国有既往卒中史的 AF 患者复发性卒中风险更高,但 OAC 的使用率较低。来自 Fushimi 注册研究的二级预防队列中,复发性卒中风险较低,但全因死亡率风险较高。